Author:
Divatia Jigeeshu Vasishtha
Publisher
Jaypee Brothers Medical Publishing
Subject
Critical Care and Intensive Care Medicine
Reference15 articles.
1. 1. Siddiqi HK, Mehra MR. COVID-19 illness in native and immuno-suppressed states: A clinical–therapeutic staging proposal. J Heart Lung Transplant 2020;39(5):405–407. DOI: 10.1016/j.healun. 2020.03.012.
2. 2. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of COVID-19–Final report. N Engl J Med 2020;383(19):1813–1826. DOI: 10.1056/NEJMoa2007764.
3. 3. Strategic Advisory Group of Experts on Immunization (SAGE). https://www.who.int/groups/strategic-advisory-group-of-experts-on-immunization/covid-19-materials [Accessed July 17, 2022].
4. 4. Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19. N Engl J Med 2022;386(15):1397–1408. DOI: 10.1056/NEJMoa2118542.
5. 5. Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, et al. Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients. N Engl J Med 2022;386(6): 509–520. DOI: 10.1056/NEJMoa2116044.